Induction of indoleamine 2, 3-dioxygenase by death receptor activation contributes to apoptosis of melanoma cells via mitochondrial damage-dependent ROS accumulation

Cellular Signalling

Volumn 22, Issue 2, 2010, Pages 197-211

  Cetindere, Turgut ^a   Nambiar, Sandeep ^a   Santourlidis, Simeon ^a   Essmann, Frank ^b   Hassan, Mohamed ^a,c,d  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Apoptosis; ASK1; IDO; JNK; Melanoma

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 8; DEATH RECEPTOR; FAS ANTIBODY; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; PROTEIN BID; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME INDUCTION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MELANOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 8; CELL LINE, TUMOR; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASE 5; MELANOMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECEPTORS, DEATH DOMAIN; RNA INTERFERENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70450222109     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2009.09.013     Document Type: Article

References (34)

1. Beddingfield F.C. Oncologist 8 (2003) 459
2. Rietschel P., Wolchok J.D., Krown S., Gerst S., Jungbluth A.A., Busam K., et al. J. Clin. Oncol. 10 (2008) 2299
3. Mellor A.L., and Munn D.H. Immunol. Today 20 (1999) 469
4. Jung I.D., Lee C.M., Jeong Y.I., Lee J.S., Park WS W.S., Han J., et al. FEBS Lett. 581 (2007) 1449
5. Mohib K., Guan Q., Diao H., Du C., and Jevnikar A.M. Am. J. Physiol. Renal. Physiol. 293 (2007) 801
6. Hassan M., Mirmohammadsadegh A., Selimovic D., Nambiar S., Tannapfel A., and Hengge U.R. Cell. Mol. Life Sci. 62 (2005) 2015
7. Taylor M.W., and Feng G.S. FASEB J. 5 (1991) 2516
8. Jeong Y.I., Kim S.W., Jung I.D., Lee J.S., Chang J.H., Lee CM C.M., et al. J. Biol. Chem. 284 (2009) 3700
9. Fujigaki H., Saito K., Fujigaki S., Takemura M., Sudo K., Ishiguro H., et al. J. Biochem. 139 (2006) 655
10. Ortis F., Pirot P., Naamane N., Kreins A.Y., Rasschaert J., Moore F., et al. Diabetologia 51 (2008) 1213
11. Peng Y., Gallagher S.H., Landmann R., Haines K., and Murr M.M. J. Gastrointest. Surg. 10 (2006) 837
12. Jin F., Liu X., Zhou Z., Yue P., Lotan R., Khuri F.R., et al. Cancer Res. 65 (2005) 6354
13. Hassan M., Feyen O., and Grinstein E. Cell Oncology 31 6 (2009)
14. Hassan M., Alaoui A., Feyen O., Mirmohammadsadegh A., Essmann F., Tannapfel A., et al. Oncogene 27 (2008) 4557
15. Selimovic D., Hassan M., Haikel Y., and Hengge U.R. Cell. Signal. 20 (2008) 311
16. Büchau A.S., Hassan M., Kukova G., Lewerenz V., Kellermann S., Würthner J.U., et al. J. Invest. Dermatol. 127 (2007) 2596
17. Hassan M., Selimovic D., Ghozlan H., and Abdel-Kader O. Hepatology 49 (2009) 1469
18. Hassan M., Selimovic D., Ghozlan H., and Abdel-Kader O. Cell. Signal. 19 (2007) 301
19. Hassan M., Ghozlan H., and Abdel-Kader O. Virology 333 (2005) 324
20. Hassan M., Ghozlan H., and Abdel-Kader O. Cell. Signal. 16 (2004) 1375
21. Erhardt A., Hassan M., Heintges T., and Häussinger D. Virology 292 (2002) 272
22. Feng G.S., and Taylor M.W. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7144
23. Daubener W., Wanagat N., Pilz K., Seghrouchni S., Fischer H.G., and Hadding U. J. Immunol. Methods 168 (1994) 39
24. Tas S.W., Vervoodeldonk M.J., Haiji N., Schuitemaker J.H., Van der Sluijs K.F., May M.J., et al. Blood 110 (2007) 1540
25. Platanias L.C. J. Interferon Cytokine Res. 25 (2005) 732
26. Chon S.Y., Hassanain H.H., Pine R., and Gupta S.L. J. Interferon Cytokine Res. 15 (1995) 517
27. Foss G.S., and Prydz H. J. Biol. Chem. 274 (1999) 35196
28. Martin E., Nathan C., and Xie Q.W. J. Exp. Med. 180 (1994) 977
29. Fujigaki S., Saito K., Sekikawa K., Tone S., Takikawa O., Fujii H., et al. Eur. J. Immunol. 3 (2001) 2313
30. Friberg M., Jennings R., Alsarraj M., Dessureault S., Cantor A., Extermann M., et al. Int. J. Cancer 101 (2002) 151
31. Burke F., Knowles R.G., East N., and Balkwill F.R. Int. J. Cancer 60 (1995) 115
32. Konan K.V., and Taylor M.W. J. Biol. Chem. 271 (1996) 19140
33. Hassanain H.H., Chon S.Y., and Gupta S.L. J. Biol. Chem. 268 (1993) 5077
34. Chon S.Y., Hassanain H.H., Pine R., and Gupta S.L. J. Interferon Cytokine Res. 15 (1995) 517